Novo Nordisk· @novonordisk · X·· 9 天前AI 评分40
AI 导读
#新闻稿:一项3期试验的新事后分析显示,起始BMI低于27的MASH患者同样能从治疗中获益。详情请见我们的新闻稿:https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=920080
正文
#PRESS: New post hoc analysis from a phase 3 trial shows that people with MASH and a starting BMI lower than 27 also benefit from treatment. Get all the details in our press release here: https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=920080
来源:Novo Nordisk · x.com